Percutaneous ablation for localised kidney tumours
A recent study reported in European Urology by investigators at [...]
Avelumab plus axitinib granted FDA approval for advanced kidney cancer
The Food and Drug Administration (FDA) in the United States [...]
Percutaneous cryoablation for stage T1b tumours
A recent study published in Cardiovascular and Interventional Radiology this [...]
PD-1, PD-L1 and PD-L2 levels differ between patients
In a recent study, published in BMC Cancer last month, [...]
Advances in systemic treatments for kidney cancer
In this video interview, Professor Jens Bedke, Professor of Urology [...]
CAR can be used to indicate survival in kidney cancer patients
A recent study with Japanese patients, published in Urologic Oncology [...]
Overall survival data for kidney cancer patients treated with high dose interleukin-2
A retrospective study recently reported in Journal for Immunotherapy of [...]
Complete response of kidney cancer brain metastases to cabozantinib
A recent case study, reported in Case Reports in Urology, [...]
Immune-related adverse events to nivolumab associated with survival
A real-world study recently reported in Journal for Immunotherapy of [...]
Clinical significance of PD-1 and PD-L1 receptors in kidney cancer
A recent study, published in Cancer Science this month, suggests [...]
